Home Health Merck, Moderna Stocks Soar After Melanoma Trial Success
Health

Merck, Moderna Stocks Soar After Melanoma Trial Success

Key Points

Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising results when it comes to fighting skin cancer. A late-stage trial showed that the mRNA vaccine helped reduce the recurrence of melanoma. Sam Fazeli of Bloomberg Intelligence has more.

Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising results when it comes to fighting skin cancer. A late-stage trial showed that the mRNA vaccine helped reduce the recurrence of melanoma. Sam Fazeli of Bloomberg Intelligence has more. (Source: Bloomberg)
Merck (ORG) Moderna Stocks Soar (ORG) Moderna (ORG) Sam Fazeli (PERSON) Bloomberg Intelligence (ORG) Bloomberg (PERSON)
Originally published by Bloomberg Markets Read original →